Katherine Pratte, MSPH, PhD

Katherine Pratte
Katherine A. Pratte, MSPH, PhD, is a researcher at National Jewish Health. Dr. Pratte is in the Division of Biostatistics and Bioinformatics.
Office of Academic Affairs
Division of Biostatistics and Bioinformatics
Research AreasResearch Areas
  • Analysis of data from basic science experiments
  • Basic Science
  • High-Throughput Data
  • In Vitro Diagnostic
  • Observational Studies and Clinical Trials
  • Translational Research

Special Interests

Proteomic and multi-omics research
Research Interests
Observational and clinical trials
Pulmonary disorders
Cardiovascular disease


University of Colorado Denver, Aurora, Co, PhD Clinical Science
University of Colorado Health Science Center, Denver, Co, MSPH Epidemiology/Biostatistics
Northwestern State University, Natchitoches, La, BS Microbiology & Zoology


Serban KA, Pratte KA, Strange C, et al. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease. EBioMedicine. 2022;84:104262.

Godbole S, Labaki WW, Pratte KA, et al. A Metabolomic Severity Score for Airflow Obstruction and Emphysema. Metabolites. 2022;12(5).

Axelsson GT, Gudmundsson G, Pratte KA, et al. The Proteomic Profile of Interstitial Lung Abnormalities. Am J Respir Crit Care Med. 2022;206(3):337-346.

Serban KA, Pratte KA, Bowler RP. Protein Biomarkers for COPD Outcomes. Chest. 2021;159(6):2244-2253.

Pratte KA, Curtis JL, Kechris K, et al. Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD. Respir Res. 2021;22(1):127.

Ask a Question through MyChart

Sign in to your MyChart account to communicate with your care team, manage appointments, and more. Create an Account

Contact Information

  • Office: 303.398.1449

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.


Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.